Several justices wrestled with the $6 billion bankruptcy plan for OxyContin maker Purdue Pharma that would shield the Sackler family, who own the company, from civil lawsuits over the toll of the opioid epidemic.

The justices put the OxyContin manufacturer bankruptcy settlement – that would have shielded the wealthy Sackler family owners from lawsuits in the opioid crisis – on hold until December.